Bath & Body Works (NYSE:BBWI – Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.40 by ($0.05), FiscalAI reports. The business had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business’s quarterly revenue was down 1.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.49 EPS. Bath & Body Works updated its FY 2025 guidance to 2.870- EPS and its Q4 2025 guidance to 1.700- EPS.
Bath & Body Works Stock Performance
Bath & Body Works stock opened at $15.86 on Thursday. Bath & Body Works has a fifty-two week low of $15.65 and a fifty-two week high of $41.87. The stock has a market cap of $3.27 billion, a P/E ratio of 4.77, a price-to-earnings-growth ratio of 0.86 and a beta of 1.53. The firm’s fifty day moving average price is $25.07 and its 200-day moving average price is $28.34.
Bath & Body Works Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 5.0%. The ex-dividend date of this dividend is Friday, November 21st. Bath & Body Works’s payout ratio is currently 23.74%.
Hedge Funds Weigh In On Bath & Body Works
Wall Street Analyst Weigh In
A number of research firms have issued reports on BBWI. Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, November 12th. Wall Street Zen cut Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Jefferies Financial Group reduced their target price on shares of Bath & Body Works from $32.00 to $28.50 and set a “hold” rating for the company in a research note on Monday, October 13th. UBS Group cut their price target on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a report on Friday, August 29th. Finally, Telsey Advisory Group reiterated an “outperform” rating and issued a $38.00 price objective on shares of Bath & Body Works in a research note on Thursday. Ten research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $38.18.
Get Our Latest Research Report on BBWI
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Read More
- Five stocks we like better than Bath & Body Works
- Industrial Products Stocks Investing
- NVIDIA Just Proved the AI Boom Is Bigger Than Anyone Thought
- Using the MarketBeat Dividend Tax Calculator
- Why Target Stock May Keep Falling Despite a 5% Dividend Yield
- Investing in the High PE Growth Stocks
- Is Tesla Setting Up for a Year-End Rebound—or a Collapse?
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
